Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002574413 | SCV003487193 | likely benign | Nemaline myopathy 2 | 2023-09-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002574414 | SCV003565461 | uncertain significance | Inborn genetic diseases | 2021-07-14 | criteria provided, single submitter | clinical testing | The c.4973T>A (p.L1658H) alteration is located in exon 41 (coding exon 39) of the NEB gene. This alteration results from a T to A substitution at nucleotide position 4973, causing the leucine (L) at amino acid position 1658 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |